Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)

2010724 citationsJournal Articlehybrid Open Access

Authors

Pascale Massin · Hôpital Lariboisière

Francesco Bandello · University of Udine

Justus G. Garweg · University of Bern

Lutz L. Hansen · University Medical Center Freiburg

Simon Harding · University of Liverpool

Michael Larsen · University of Copenhagen

Paul Mitchell ·

Abstract

Ranibizumab is effective in improving BCVA and is well tolerated in DME. Future clinical trials are required to confirm its long-term efficacy and safety.

Topics & Keywords

Retinal Diseases and Treatments Retinal Imaging and Analysis Retinal and Optic Conditions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

Volume 33, Issue 11, pp. 2399-2405

DOI: 10.2337/dc10-0493

Field-Weighted Citation Impact: 47.40